Inventor · disambiguated record
Ekaterina Deyanova
Also filed as: DEYANOVA EKATERINA G · DEYANOVA Ekaterina
12 granted patents·10 pending applications·19 citations·filing 2017–2025
86Inventor score
Top patents by PatentIndex Score
22 records- 0195US11008395B2Antibodies against IL-7R alpha subunit and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2020·Granted May 18, 2021·5 cites·25 claims
- 0294US12312403B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Granted May 27, 2025·1 cites·17 claims
- 0394US10077306B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 18, 2018·7 cites·22 claims
- 0493US10533052B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 14, 2020·4 cites·30 claims
- 0587US2024209083A1Antibodies against tim3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0686US11591392B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 28, 2023·1 cites·19 claims
- 0778US2024174749A1Methods of treating cancer with antibodies against tim3BRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0878US2024417478A1Antibodies against il-7r alpha subunit and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0977US12173069B2Antibodies binding to vista at acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Dec 24, 2024·1 cites·28 claims
- 1076US12435136B2Antibodies binding to ILT4FIVE PRIME THERAPEUTICS INC·Filed 2022·Granted Oct 7, 2025·0 cites·42 claims
- 1176US2025326841A1Antibodies against tim3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1276US2025115664A1Antibodies against tim3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1375US2025129166A1Antibodies Binding to Vista at Acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1471US11919962B2Antibodies against IL-7R alpha subunit and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Mar 5, 2024·0 cites·29 claims
- 1568US2025197494A1Methods of treating cancer with antibodies against tim3BRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1664US11401328B2Antibodies binding to ILT4FIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Aug 2, 2022·0 cites·41 claims
- 1764US2024228664A9Antibodies Binding to Human PAD4 and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1862US12129297B2Antibodies against TIM3 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 29, 2024·0 cites·10 claims
- 1961US2021363242A1Methods of treating cancer with antibodies against tim3BRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2052US12091462B2Antibodies binding to vista at acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Sep 17, 2024·0 cites·20 claims
- 2151US12110337B2Anti-CD27 antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 8, 2024·0 cites·25 claims
- 2242US2025361320A1Anti-ceacam5 antibodies and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ekaterina Deyanova files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →